RecruitingPhase not listedNCT07379827
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Sponsor: Bristol-Myers Squibb
Oklahoma City, OK · Tulsa, OK · +53 more sites
1 recruiting schizophrenia studies with a site in Tulsa, OK.
Sponsor: Bristol-Myers Squibb
Oklahoma City, OK · Tulsa, OK · +53 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.